Safety and Efficacy of Belatacept Conversion Following Kidney Transplant

被引：0
|
作者：
Bixby, A. [1 ]
Hampton, A. [2 ]
Ecabert, D. [1 ]
Burrelli, C. [1 ]
机构：
[1] Univ Hosp Cleveland, Med Ctr, Cleveland, OH USA
[2] Ohio Northern Univ, Ada, OH USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2023年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B212
引用
收藏
页码：S850 / S850
页数：1
相关论文
共 50 条
  • [11] Belatacept conversion in adolescent and young adult kidney transplant recipients
    Gupta, Charu
    Petyak, Christy
    Sgambat, Kristen
    Moudgil, Asha
    CLINICAL TRANSPLANTATION, 2023, 37 (03)
  • [12] Kidney Transplant Function After Late Conversion to Belatacept (Nulojix®)
    Brakemeier, S.
    Duerr, M.
    Wiesener, M.
    Tobias, B.
    Budde, K.
    Klemens, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [13] Belatacept Conversion in Kidney Transplant: With or without Calcineurin Inhibitor Taper
    Elmasri, A.
    Valdepenas, B.
    Benken, S.
    Hajjiri, Z.
    Benken, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S845 - S846
  • [14] Safety and Efficacy of Belatacept in Heart Transplant Patients with Chronic Kidney Disease or Intolerance to Calcineurin Inhibitors
    Yehya, A.
    Ham, P.
    Pearston, A.
    Ingemi, A.
    Cohan, D.
    Mandel, J.
    Badiye, A.
    Herre, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S517 - S517
  • [15] An Integrated Safety Profile Analysis of Belatacept in Kidney Transplant Recipients
    Grinyo, Josep
    Charpentier, Bernard
    Pestana, Jose Medina
    Vanrenterghem, Yves
    Vincenti, Flavio
    Reyes-Acevedo, Rafael
    Apanovitch, Anne Marie
    Gujrathi, Sheila
    Agarwal, Mamta
    Thomas, Dolca
    Larsen, Christian P.
    TRANSPLANTATION, 2010, 90 (12) : 1521 - 1527
  • [16] Safety of Belatacept in HIV-Positive Kidney Transplant Recipients
    El Sakhawi, K.
    Scemla, A.
    Bertrand, D.
    Garrouste, C.
    Malvezzi, P.
    Grimbert, P.
    Matignon, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 920 - 920
  • [17] SAFETY OF BELATACEPT IN HIV-POSITIVE KIDNEY TRANSPLANT RECIPIENTS
    El Sakhawi, K.
    Scemla, A.
    Bertrand, D.
    Garrouste, C.
    Malvezzi, P.
    Remy, P.
    Moktefi, A.
    Ingels, A.
    Kheav, D.
    Melica, G.
    Grimbert, P.
    Matignon, M.
    TRANSPLANT INTERNATIONAL, 2020, 33 : 12 - 12
  • [18] Safety and Efficacy of Very Early Conversion to Belatacept in Pediatric Kidney Transplantation with Transplant-Associated Thrombotic Microangiopathy: Case Study and Review of Literature
    Acharya, Ratna
    Clapp, William
    Upadhyay, Kiran
    CLINICS AND PRACTICE, 2024, 14 (03) : 882 - 891
  • [19] Impact of Belatacept Conversion on Kidney Transplant Function, Histology and Gene Expression
    Sanghi, P.
    Gupta, G.
    Kumar, D.
    Reeve, J.
    Levy, M.
    Sharma, A.
    Fattah, H.
    Kimball, P.
    Massey, H.
    King, A.
    Halloran, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 398 - 398
  • [20] Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients
    Koppula, Sireesha
    Yost, Sarah E.
    Sussman, Amy
    Bracamonte, Erika R.
    Kaplan, Bruce
    CLINICAL TRANSPLANTATION, 2013, 27 (04) : 591 - 597
12345